comparemela.com
Home
Live Updates
Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q1 2022 Results - Earnings Call Transcript : comparemela.com
Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q1 2022 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc (NASDAQ:NASDAQ:ONCT) Q1 2022 Earnings Conference Call May 5, 2022, 5:00 PM ET Company Participants James Breitmeyer – President & Chief Executive Officer...
Related Keywords
Brookline
,
Massachusetts
,
United States
,
Dana Farber Cancer Institute
,
China
,
California
,
San Diego
,
Chicago
,
Illinois
,
Ukraine
,
American
,
Kumar Raja
,
Carl Byrnes
,
James Breitmeyer
,
Hartaj Singh
,
Kaveri Pohlman
,
Shubhendu Sen Roy
,
Shubhendu Sen Kumar
,
Jim Breitmeyer
,
Salim Yazji
,
Richard Vincent
,
Vincent Salim Yazji
,
Brian Petitt
,
Company Participants
,
American Society Of Clinical Oncology Meeting
,
California Institute For Regenerative Medicine
,
Karolinska Institute
,
National Institutes Of Health
,
Oncternal Therapeutics Inc
,
Oncternal Therapeutics Inc Third Quarter
,
Uc San Diego School Of Medicine
,
Oncternal Therapeutics
,
Conference Call May
,
Chief Executive
,
Chief Financial
,
Chief Medical
,
Northland Capital
,
Sen Roy
,
Brookline Capital
,
Inc Third Quarter
,
First Quarter
,
Investor Relations
,
Safe Harbor
,
Private Securities Litigation Reform
,
Orphan Receptor
,
American Society
,
Clinical Oncology Meeting
,
California Institute
,
Regenerative Medicine
,
National Institutes
,
Diego School
,
Registrational Phase
,
I Lli Ll
,
Diffuse Largeb Cell Lymphoma
,
Eastern Europe
,
Im Shubhendu Sen Kumar
,
Shanghai Pharma
,
Thanks And
,
Miltenyi Prodigy
,
Rich Vincent Salim Yazji
,
comparemela.com © 2020. All Rights Reserved.